PAR 4.35% 22.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3526

  1. 572 Posts.
    lightbulb Created with Sketch. 239
    Mozz, it is against company stated guidelines to have the same person holding both CEO & the Chairman role... We were told at the AGM, that the board were looking / working on it, but 6 weeks on and nada from the board on where they are in sorting this out.... As of right now, this company has a CEO, who also has the role of Chairman, plus the CEO & Chairman role at another listed ASX company.... Stupidity at its finest...
    If we (I) want to go a little deeper, the PAR board, has a person stepping back into a position (CEO) and taking on that higher salary, while openly admitting that they are outsourcing a large part of that role to a 3rd party (plexus & pond)... Seriously, WTF.... The governance here is staggering...
    I love your work on the science, but will you ever be critical of the company and the way they operate?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.010(4.35%)
Mkt cap ! $76.95M
Open High Low Value Volume
23.5¢ 23.5¢ 21.5¢ $258.8K 1.172M

Buyers (Bids)

No. Vol. Price($)
1 10139 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 6077 1
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.